Deals channel feed – Endpoints News

Deals channel feed

Lilly makes a move for long-acting incretins in tech deal with Swedish biotech

Last month

Agenus quickly exits CDMO business by selling assets to Zydus for $75M upfront

Last month

BioNTech presents impressive early data for PD-L1xVEGF in mesothelioma

Last month

Pyx Health buys FarmboxRx to reach more Medicaid and Medicare members

Last month

Regeneron makes $80M obesity deal with Hansoh

Last month

Sanofi to snap up Blueprint Medicines and mastocytosis drug Ayvakit for $9.1B

Last month

Bristol Myers bets $1.5B on BioNTech's PD-L1xVEGF from Biotheus

Last month

As a challenging first half nears a close, biopharma uncertainty persists

Last month

Astellas licenses Claudin18.2 ADC from China’s Evopoint Biosciences

Last month

Post-Hoc Live: Is biotech sentiment really as bad as it seems?

Last month

Novartis won bidding war for kidney drug as Regulus' top three execs expect to make over $100M combined

Last month

Lilly to buy non-opioid pain biotech SiteOne for up to $1B

Last month

Biogen taps City Therapeutics in RNAi deal worth up to $1B

Last month

Blackstone's GRIN inks epilepsy licensing deal with Angelini, closes $140M Series D

Last month

TCG's R&D venture team makes a T cell engager deal with Shanghai biotech

Last month

Updated: Hinge Health jumped 18% on its first day as the digital health IPO market reawakens

Last month

Sanofi makes $470M move for Vigil's Alzheimer's drug, while another asset returns to Amgen

Last month

BioNTech invests £1B in growing UK footprint under expanded pact with government

Last month

Genentech expands deal with molecular glue biotech Orionis for $105M upfront

Last month

Altos Labs buys anti-aging startup Dorian Therapeutics

Last month

Pfizer joins PD-1xVEGF race with $1.25B upfront to Chinese biotech 3SBio

Last month

Retro Biosciences inks blood disorder deal as Sam Altman-backed biotech seeks $1B in funds

Last month

Why Regeneron is buying 23andMe

Last month

Regeneron plans to buy 23andMe for $256M

Last month

First page Previous page 123 4 5 Next page Last page